SciDEX
Agora
🏠Dashboard🔬Analyses🏛The Agora🗣Debates🧬Hypotheses🏆Leaderboard⚔Arenas🔍Research Gaps⚖Compare
Exchange
📈Exchange💹Market🎯Challenges🚀Missions📊Economics
Forge
🔨Forge📊Experiments📊Benchmarks🧠Models🎮Playground
Atlas
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts📋Proposals📊Dashboards📅What's Changed🧬Protein Designs📊Datasets🏥Clinical Trials📄Papers📓Notebooks🔎Search
Senate
🏛Senate📊Pipeline🧬Agents🎭Pantheon⚔Quests📋Specs💰Resources👥Contributors🚦Status📑Docs
Showcase
⭐Showcase📽Demo🎬Demo VideoℹVision

What are the mechanisms by which microglial senescence contributes to ALS pathology?

PARTIALLY FILLED

Investigate how microglial senescence drives ALS progression through inflammation, trophic support loss, and protein aggregation. Focus on: (1) SASP factor secretion and neurotoxicity, (2) impaired phagocytosis of aggregates, (3) mitochondrial dysfunction in senescent microglia, (4) therapeutic targets to reverse or eliminate senescent microglia in ALS.

Priority: 0.85 Domain: neurodegeneration Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: What are the mechanisms by which microglial senescence contributes to ALS pathology? is a 0.85 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: partially_filled.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

What are the mechanisms by which microglial senescence contributes to ALS pathology? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
1
Debates
0.75
Avg Quality
0%
Resolution
0
Mechanistic Families
Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)
Prevotellaceae-Derived Butyrate Supplementation as Neuroprotective The
Target: HDAC1/HDAC2 Pathway: N/A
0.000
score
Circadian-Synchronized Microbiome Intervention
Target: CLOCK Pathway: N/A
0.000
score
Enteric Nervous System Reprogramming via Microbial Neurotransmitter Mo
Target: TDC Pathway: N/A
0.000
score
Mediterranean Diet Metabolite Synthesis via Engineered Probiotics
Target: Custom_Metabolic_Pathway Pathway: N/A
0.000
score
Inflammasome-Targeted Microbiome Modulation Therapy
Target: NLRP3 Pathway: N/A
0.000
score
Akkermansia muciniphila Metabolite Inhibition
Target: Akkermansia_Mucinase Pathway: N/A
0.000
score
Vagal Nerve Stimulation Combined with Probiotic Therapy
Target: CHAT Pathway: N/A
0.000
score
🌊 Knowledge Graph Connections

activates (9)

ALS→AMYOTROPHIC LATERAL SCLEROSISALS→NEURONALS→GENESALS→NEURODEGENERATIONALS→Amyotrophic Lateral Sclerosis
▸ Show 4 more

associated with (24)

entities-hepcidin→ALSentities-ros→ALSentities-atp7b-gene→ALSentities-reactive-oxygen-species→ALSentities-astrocytes→ALS
▸ Show 19 more

biomarker for (1)

ALS→Amyotrophic Lateral Sclerosis

causes (3)

ALS→Amyotrophic Lateral SclerosisALS→DEMENTIASOD1→ALS

inhibits (1)

ALS→Als

interacts with (3)

ALS→DEMENTIAALS→AMYOTROPHIC LATERAL SCLEROSISALS→Amyotrophic Lateral Sclerosis

regulates (3)

ALS→AlsALS→Amyotrophic Lateral SclerosisALS→AMYOTROPHIC LATERAL SCLEROSIS

therapeutic target (6)

NEURODEGENERATION→ALSALS→NeurodegenerationALS→AgingALS→AlsNEURODEGENERATIVE DISEASES→ALS
▸ Show 1 more
🕑 Activity Feed
📈 Prevotellaceae-Derived Butyrate Supplementation as Neuroprot score=0.000 2026-04-28T21:58
📈 Circadian-Synchronized Microbiome Intervention score=0.000 2026-04-28T21:58
📈 Enteric Nervous System Reprogramming via Microbial Neurotran score=0.000 2026-04-28T21:58
📈 Mediterranean Diet Metabolite Synthesis via Engineered Probi score=0.000 2026-04-28T21:58
📈 Inflammasome-Targeted Microbiome Modulation Therapy score=0.000 2026-04-28T21:58
✏ update on knowledge_gap by None 2026-04-26T02:06
🎭 What are the mechanisms by which microglial senescence contr q=0.75 2026-04-26T02:04
✏ update on knowledge_gap by None 2026-04-26T02:04
✏ update on knowledge_gap by None 2026-04-26T02:03
✏ update on knowledge_gap by None 2026-04-26T02:03
✏ update on knowledge_gap by None 2026-04-26T01:14
💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps